GeneDx Holdings Corp

For the period ended Dec 31, 2023. Filed Feb 23, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 23, 2024

WGS$54.83-16.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders' Equity

(in thousands, except share amounts)

	Class A Common Stock
Shares · Par Value · Additional paid-in capital · Accumulated deficit · Accumulated other comprehensive income · Total stockholders’ equity
Balance at December 31, 2021	7,352,958		$1		$963,543		$(575,441)		—		$388,103
Net loss	—		—		—		(548,980)		—		(548,980)
Common stock issued pursuant to stock option exercises	333,988		—		2,948		—		—		2,948
Stock based compensation expense	—		—		41,975		—		—		41,975
Shares issued for PIPE, net of issuance costs	1,515,152		—		197,659		—		—		197,659
Shares issued for acquisition (1)	2,424,243		—		172,000		—		—		172,000
Vested restricted stock units converted to common stock	146,724		—		—		—		—		—
Balance at December 31, 2022	11,773,065		$1		$1,378,125		$(1,124,421)		$—		$253,705
Net loss		—		—		(175,767)		—		(175,767)
Common stock issued pursuant to stock option exercises	50,444		—		285	—		—		285
Stock-based compensation expense	—		—		(326)		—		—		(326)
Other comprehensive income, net of tax	—		—		—		—		425		425
Vested restricted stock units converted to common stock	431,671		—		—		—		—		—
Issuance of Class A common shares in registered direct offering, net of issuance costs	676,868		—		7,564		—		—		7,564
Issuance of Class A common shares for the first Milestone Payment	701,460		—		6,692		—		—		6,692
Fractional shares adjustment	29,603		—		—		—		—		—
Issuance of Class A common shares in underwritten public offering, net of issuance costs	12,315,752		1		135,438		—		—		135,439
Balance at December 31, 2023	25,978,863		$2		$1,527,778		$(1,300,188)		$425		$228,017

(1)Of the 2.4 million shares issued for acquisition,251,965 shares were held by an escrow agent for a one year escrow period. During this period, the seller retained all rights with respect to the escrow shares, including voting rights and rights to receive dividends and other distributions on such escrow shares.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.